Retatrutide

Retatrutide (LY3437943) is a novel triple hormone receptor agonist peptide engineered for metabolic and endocrine research. Uniquely, it simultaneously activates the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors — making it one of the most advanced multi-agonist compounds available for laboratory investigation. Retatrutide has been studied extensively for its effects on energy expenditure, lipid metabolism, insulin sensitivity pathways, and body composition models. Its triple agonist mechanism distinguishes it from single or dual-agonist analogues, offering researchers a powerful tool for exploring integrated metabolic regulation. AllMyPeptides supplies Retatrutide as a high-purity lyophilised research peptide with every batch independently tested by independent third-party laboratories using HPLC and mass spectrometry to verify 99%+ purity. A comprehensive Certificate of Analysis is included with every order for complete research traceability.